TEMAPHARM
Timeline
11 events since 2019Filings
Financial
Establishments
2020202220242026
Deadline for the 2026 accounts: 31-07-2027
2026
Annual accounts 2025 filed NBBmicro format · 36 days before the deadline
2025
Highest result from 2019 to 2025 net €84,991 ▲14.9% The operating result of €108,862 and the net result of €84,991 are both a record.
Registered in the Peppol Directory Reachable for e-invoices through 0208:0727468425
Annual accounts 2024 filed PDFmicro format · 41 days before the deadline
2024
Annual accounts 2023 filed PDFmicro format · 37 days before the deadline
2023
Annual accounts 2022 filed PDFmicro format · 38 days before the deadline
2022
Annual accounts 2021 filed PDFmicro format · 18 days late
2021
Annual accounts 2020 filed PDFmicro format · 31 days late
2020
Annual accounts 2019 filed PDFmicro format · 24 days before the deadline
2019
IncorporationFounding capital of €6,200, 100 shares · Founders: WERY Benoît Joseph Ghislain and BEAUJEAN Laurence Geneviève Dominique Marie · Appointments: WERY Benoît Joseph Ghislain (director) and BEAUJEAN Laurence Geneviève Dominique Marie (director) · published on 28-05-20197 points ▸
- Registered office clause, Avenue des Alouettes 11, 4121 Neupré
- Director appointment, WERY Benoît Joseph Ghislain (director (not named in the articles))
- Director appointment, BEAUJEAN Laurence Geneviève Dominique Marie (director (not named in the articles))
- Founder, WERY Benoît Joseph Ghislain
- Founder, BEAUJEAN Laurence Geneviève Dominique Marie
- Founding capital, €6,200, 100 shares
- 100 shares
- The deed holds 7 more points.
First establishment Avenue des Alouettes 11, Neupré
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank